Lenka Kasikova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
Journal: NPJ precision oncology
Published: June 12, 2025
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2024
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Journal: Cell death & disease
Published: November 17, 2022
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Journal: Nature communications
Published: September 29, 2022
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines.
Journal: Oncoimmunology
Published: July 28, 2022
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 13, 2021
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.
Journal: Trends in cancer
Published: December 02, 2021
Detection of immunogenic cell death and its relevance for cancer therapy.
Journal: Cell death & disease
Published: October 09, 2020
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2020
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death.
Journal: Methods in enzymology
Published: February 01, 2020
Last Updated: 09/26/2026